Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more

White Paper: Evidence requirements for coverage of medical technologies in the Netherlands

Get insights from MTRC White Papers to advance your understanding of five rapid HTA reports from the Netherlands 

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Health Economic Publication Digest: The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest.

In a recent publication, Geuzinge et al. revised the Dutch healthcare economic evaluation guideline, drawing on recommendations from an independent national HTA committee. Key updates include a reduced discount rate for costs, the integration of informal caregivers’ quality of life, the inclusion of indirect medical costs in life years gained, and enhanced guidance for probabilistic and value of information analyses. The guideline provides up-to-date recommendations for economic evaluations in the Netherlands, supporting policy decisions from a broad societal perspective.

Access the full-text article here.